CORCEPT THERAPEUTICS
US Stocks: Corcept Therapeutics shares surge 32% as lead drug gets FDA nod for ovarian cancerCorcept Therapeutics shares surged after the FDA approved its drug, Lifyorli, for a tough ovarian cancer. This new therapy, combined with c...
US stock market today ends mixed: Nasdaq gains but S&P 500, Dow fall for third day as November jobs report, oil price crash and AI selloff raise concernsStock market today: US stocks saw a mixed close as investors digested a jobs report showing unexpected gains but also a rise in unemploymen...
- Load More